Monoclonal Antibodies as Immune Modulators for Cancer Therapy
Monoclonal antibodies may modulate immune and/or biological responses alone, or as carriers of specific agents. Monoclonal antibodies directed against tumours may be indirectly cytotoxic by modulation of antibody-dependent, cell-mediated cytotoxicity or complement-mediated cytotoxicity. Monoclonal a...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1992-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1992/205769 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Monoclonal antibodies may modulate immune and/or biological responses
alone, or as carriers of specific agents. Monoclonal antibodies directed against tumours may be indirectly
cytotoxic by modulation of antibody-dependent, cell-mediated cytotoxicity or complement-mediated
cytotoxicity. Monoclonal antibodies directed against certain tumour cell receptors may alter the biological
behaviour of tumour cells such as blocking or downregulation of growth factors essential to tumour cell
proliferation. Monoclonal antibodies directed to certain receptors on host immune cells. such as the CD3
receptor on T lymphocytes. may activate those cells and increase their cytotoxicity. Antitumour monoclonal
antibodies can serve as carriers of interferons, interleukin-2, tumour necrosis factor and other lymphokines
and cytokines to modulate selectively the cytotoxic potential of immune cells in the vicinity of tumour cells.
Cytotoxic chemotherapy agents conjugated to antitumour monoclonal antibodies may be processed
differently so that they bypass certain mechanisms of drug resistance. The penultimate application of
monoclonal antibodies in cancer therapy is to combine various monoclonal antibodies and immunoconjugates
for selective combination therapy based on known antigenic tumour cell determinants and the
status of the host immune system. |
|---|---|
| ISSN: | 1180-2332 |